Cybin Inc. (NYSE AMERICAN: CYBN)
$0.31
-0.0128 ( -3.94% ) 4.9M
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Market Data
Open
$0.31
Previous close
$0.32
Volume
4.9M
Market cap
$239.31M
Day range
$0.30 - $0.33
52 week range
$0.25 - $0.74
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | Jul 05, 2024 |
6-k/a | Quarterly Reports | 3 | Jun 27, 2024 |
6-k | Quarterly Reports | 3 | Jun 26, 2024 |
40-f | Other | 114 | Jun 26, 2024 |
6-k | Quarterly Reports | 3 | Jun 20, 2024 |
6-k | Quarterly Reports | 3 | Jun 11, 2024 |
6-k | Quarterly Reports | 3 | May 29, 2024 |
6-k | Quarterly Reports | 3 | May 14, 2024 |
6-k | Quarterly Reports | 3 | May 06, 2024 |
6-k | Quarterly Reports | 3 | Apr 25, 2024 |